Authors:
Conner, AL
Wray, H
Cottrell, J
Wilding, IR
Citation: Al. Conner et al., A scintigraphic study to investigate the potential for altered gut distribution of loperamide from a loperamide-simethicone formulation in man, EUR J PH SC, 13(4), 2001, pp. 369-374
Citation: Sp. Newman et al., Human lung deposition data: the bridge between in vitro and clinical evaluations for inhaled drug products?, INT J PHARM, 208(1-2), 2000, pp. 49-60
Authors:
Dobson, CL
Davis, SS
Chauhan, S
Sparrow, RA
Wilding, IR
Citation: Cl. Dobson et al., Does the site of intestinal delivery of oleic acid alter the ileal brake response?, INT J PHARM, 195(1-2), 2000, pp. 63-70
Citation: Ph. Marathe et al., Effect of altered gastric emptying and gastrointestinal motility on metformin absorption, BR J CL PH, 50(4), 2000, pp. 325-332
Citation: Ir. Wilding et al., Gastrointestinal spread of oral prolonged-release mesalazine microgranules(Pentasa) dosed as either tablets or sachet, ALIM PHARM, 14(2), 2000, pp. 163-169
Citation: Ir. Wilding, Evolution of the Biopharmaceutics Classification System (BCS) to oral Modified Release (MR) formulations; what do we need to consider?, EUR J PH SC, 8(3), 1999, pp. 157-159
Authors:
Dobson, CL
Davis, SS
Chauhan, S
Sparrow, RA
Wilding, IR
Citation: Cl. Dobson et al., The effect of oleic acid on the human ileal brake and its implications forsmall intestinal transit of tablet formulations, PHARM RES, 16(1), 1999, pp. 92-96
Citation: Ir. Wilding et Dl. Heald, Visualization of product performance in the gut: What role in the drug development/regulatory paradigm?, J CLIN PHAR, 39, 1999, pp. 6S-9S